Design and in vitro testing of a floatable gastroretentive tablet of metformin hydrochloride

Pharmazie

Volumn 62, Issue 2, 2007, Pages 145-148

  Basak, Subal C ^a   Rahman, J ^a   Ramalingam, M ^b  

^a ANNAMALAI UNIVERSITY   (India)

^b Fourrts (India) Laboratories Pvt Ltd   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BICARBONATE; CITRIC ACID; HYDROXYPROPYLMETHYLCELLULOSE; METFORMIN; POVIDONE;

ARTICLE; DRUG ABSORPTION; DRUG DESIGN; DRUG FORMULATION; DRUG RELEASE; DRUG RETENTION; GASTROINTESTINAL ABSORPTION; IN VITRO STUDY; TABLET FRIABILITY;

CHEMISTRY, PHARMACEUTICAL; DRUG DESIGN; HYPOGLYCEMIC AGENTS; METFORMIN; METHYLCELLULOSE; MODELS, STATISTICAL; POWDERS; SOLUBILITY; SPECTROPHOTOMETRY, ULTRAVIOLET; TABLETS;

EID: 33847127051     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2007.2.6108     Document Type: Article

References (29)

1. th Ed., Bethesda, Maryland, p. 3026.
2. st Ed., Churchill Livingstone, London, p. 247.
3. Balan G, Timmins P, Greene DS, Marathe PH (2001) In vitro-in vivo correlation (IVIVC) models for metformin after administration of modified-release (MR) oral dosage forms to healthy human volunteers. J Pharm Sci 90: 1176-1185.
4. Basak SC, Nageswara Rao K, Manavalan R, Rama Rao P (2004) Development and in-vitro evaluation of an oral floating matrix tablet formulation of ciprofloxacin. Indian J. Pharm. Sci 66: 313-316.
5. Bhansali A, Masoodi SR (2005) Efficacy of once- or twice-daily extended release metformin compared with thrice-daily immediate release metformin in type 2 diabetes mellitus. J Assoc Physicians India 53: 441-445.
6. Carr RL (1965) Evaluating the flow properties of solids. Chem Engg Sci 72: 163.
7. Carter SJ (1986) Cooper and Gunn's: Tutorial pharmacy, 6th Ed., CBS Publishers and Distributors, Delhi, p. 225.
8. Cullen E, Liao J, Lukacsko P, Niecestro R, Friedhoff L (2004) Pharmacokinetics and dose proportionality of extended-release metformin following administration of 1000, 1500, 2000 and 2500 mg in healthy volunteers. Biopharm Drug Dispos 25: 261-263.
9. Di Colo G, Falchi S, Zambito Y (2002) In vitro evaluation of a system for pH-controlled peroral delivery of metformin. J Control Release 80: 119-128.
10. Di Colo G, Zambito Y, Baggiani A, Carelli V, Serafini MF (2005) A site-specific controlled-release system for metformin. J Pharm Pharmacol 57: 565-571.
11. Fujioka K, Pans M, Joyal S (2003) Glycemic control in patients with type 2 diabetes mellitus switched from twice-daily immediate-release metformin to a once-daily extended-release formulation. Clin Ther 25: 515-529.
12. Gusler G, Gorsline J, Levy G, Zhang SZ, Weston IE, Naret D, Berner B (2001) Pharmacokinetic of gastroretentive tablets in healthy volunteers. J Clin Pharmacol. 41: 655661.
13. Higuchi T (1963) Mechanism of sustained release medication: theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J. Pharm Sci 52: 1145-1149.
14. Hwang SJ, Park H, Park K (1998) Gastric retentive drug delivery systems. Crit Rev Ther Drug Carrier Syst 15: 243-284.
15. Icikawa M, Watanabe S, Miyake Y (1991) A new multiple unit oral floating dosage system I: preparation and in-vitro evaluation of floating and sustained release capabilities. J Pharm Sci 80: 1062-1066.
16. th Ed., Controller of Publications, New Delhi, p. 470.
17. th Ed., Controller of Publications, New Delhi, p. 736.
18. Klausner EA, Lavy E, Friedman M, Hoffman A (2003) Expandable gastroretentive dosage forms. J Control Release 90: 143-162.
19. Korsmeyer RW, Gunny R, Peppas NA (1983) Mechanism of solute release from hydrophilic polymers. Int J Pharm 15: 25-35.
20. Moes AJ (1993) Gastroretentive dosage forms. Crit Rev Ther Drug Carrier Syst 10: 143-195.
21. Peppas NA (1985) Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv 60: 110-111.
22. Rosa M, Zia H, Rhodes T (1994) Dosing and testing in-vitro of a bioadhesive and a floating drug delivery system for oral applications. Int J Pharm 105: 65-70.
23. Scheen AJ (1996) Clinical pharmacokinetics of metformin. Clin Pharmacokinet 30: 359-371.
24. Shah D, Shah Y, Rampradhan M (1997) Development and evaluation of controlled release diltiazem hydrochloride microspheres using cross linked poly vinyl alcohol. Drug Devel Ind Pharm 23: 567-574.
25. Singh BN, Kim KH (2000) Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. J Control Release 63: 235-259.
26. Stepensky D, Friedman M, Raz I, and Hoffman A. (2002) Pharmacokinetic-pharmacodynamic analysis of glucose-lowering effect of metformin in diabetic rats reveals first-pass pharmacodynamic effect. Drug Metab Dispos 30: 861-868.
27. rd Ed., Pharmaceutical Press, London, p. 332.
28. The United States Pharmacopoeia 24 (2000) United States Pharmacopoeial Convention, Rockville, MD, p. 1942.
29. Yuen KH, Peh KK, Tan BL (1999) Relating in vitro/in vivo data of two controlled release metformin formulations. Drug Dev Ind Pharm 25: 613-618.